Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The comparison of exosomal miRNAs from ECM or media derived from HFF-CBD-Lamp2b cells, HFF cells, HFF-Lamp2b cells and hUCMSCs

ABSTRACT: The comparison of exosomal miRNAs from ECM or media derived from HFF-CBD-Lamp2b cells, HFF cells, HFF-Lamp2b cells and hUCMSCs

PROVIDER: PRJEB48070 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR7015680.fastq.gz	Fastqsanger.gz
	ERR7015681.fastq.gz	Fastqsanger.gz
	ERR7015682.fastq.gz	Fastqsanger.gz
	ERR7015683.fastq.gz	Fastqsanger.gz
	ERR7015684.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

The comparison of exosomal miRNAs from ECM or media derived from HFF-CBD-Lamp2b cells, HFF cells, HFF-Lamp2b cells and hUCMSCs

Project description:The next-generation sequencing technology was used to investigate the difference of RNAs content among the different types of exosomes from the media of HFF cells, HFF-Lamp2b cells and hUCMSCs, and from the ECM of HFF-CBD-Lamp2b cells

2021-10-12 | E-MTAB-10905 | biostudies-arrayexpress

HFF Cells: Control vs. Toxoplasma gondii infected

Project description:Expression profile microarray of human foreskin fibroblast cell comparing control untreated HFF cell with HFF cell infected with ME49 strain.Study on Toxoplasma gondii infection of HFF cell LncRNAs expression, for further studies on the differential exprssion of LncRNAs in HFF cell against the infection of Toxoplasma gondii research provide the basic function.

2017-01-01 | GSE92603 | GEO

Elucidating the transcriptomic response of adult hypothalamic neuron cells to cannabidiol (CBD) exposure

Project description:Cannabidiol (CBD) actions in the brain are largely complex and not fully understood. One important brain structure that is a target for CBD, and for which health-beneficial CBD consequences can be seen is the hypothalamus. Given the fundamental role of gene expression in the hypothalamus's regulatory functions, this study undertook the analysis of changes arising in hypothalamic cells’ transcriptomes following various CBD treatments. For this purpose, we used a hypothalamic cellular model, namely we employ adult-derived mHypoA-2/12 mouse cell lines. In the course of the study, the neural cells were treated with different CBD doses (ranging from 0.325 to 3 µM) and vehicle as a control for 6 and 24 hours. The experiment setup allowed us to evaluate both the dosage and time-dependent effect of CBD on hypothalamic cells, particularly on their viability, apoptosis, and transcriptome profile.

2024-08-01 | GSE270378 | GEO

Effects of CBD on the glioma stem cell molecular signature

Project description:Primary glioma stem cells cultured as neurospheres in NBL media with growth factors were subjected to treatment with the non-toxic, non-psychoactive cannabis compound cannabidiol (CBD). Control and CBD- treated cultures were used to generate RNA used to hybridize on Affymetrix DNA arrays Fluorescence intensities data were RMA-normalized using Partek software.

2015-04-17 | E-GEOD-57978 | biostudies-arrayexpress

Mock or latently infected KSHV cells (BCBL, SLK and HFF)

Project description:[original title] Mock or latently infected KSHV cells (BCBL, SLK and HFF) vs common reference (mixture of RNA from both infected and uninfected cells). Expression profiling of latently infected cells using a custom tiling microarray. SLK and HFF cells were infected and selected for rKSHV.219. Mock infected SLK and HFF cells served as controls for each of these two stably infected cells, respectively. BJAB cells served as uninfected controls for the BCBL-1 cells. Biological replicates were harvested and analyzed.

2010-03-24 | GSE20443 | GEO

Transcriptomic profiling of control and CBD treated monocyte-derived dendritic cells

Project description:Transcriptomic profiling of control and CBD treated monocyte-derived dendritic cells

2023-08-13 | GSE235310 | GEO

Canabidiol (CBD) modulates the effect of ethanol on the fibroblast cells transcriptome in vitro

Project description:Considering reports about positive role of Cannabidiol (CBD) in alcohol abuse disorders, in this study we used cellular model of human fibroblasts to analyse the effect of CBD on ethanol-treated cells. We assumed, that CBD will (to some extent), prevent adverse transcriptional changes driven by alcohol administration and this effect will be detectable on the transcriptome level. As a by-product of this analysis, ethanol and CBD alone stimulated transcriptome changes were also described. We moreover considered that CBD effects are dose and time-dependent. As a model for these analyses we selected human fibroblast cell line as a most abundant cell type in human body that express e.g. both cannabinoid receptors (CB1 and CB2) and is able to metabolize ethanol trough alcohol dehydrogenase activity.

2023-08-01 | GSE232624 | GEO

Effects of CBD on the glioma stem cell molecular signature

2015-04-17 | GSE57978 | GEO

Oral CBD treatment is associated to an anti-inflammatory gene expression signature in myeloid cells of people living with HIV

Project description:HIV-related comorbidities appear to be related to chronic inflammation, a condition characterizing people living with HIV (PLWH). Prior work indicates that cannabidiol (CBD) might reduce inflammation; however, the genetics underpinning this effect are not well investigated. Our main objective is to detect gene expression alterations in human peripheral blood mononuclear cells (PBMCs) from PLWH after at least one month of CBD treatment. We collected PBMCs from three HIV-positive subjects at baseline and after CBD treatment (at least 27 days) via single-cell RNA sequencing. We obtained a coherent signature, characterized by an anti-inflammatory activity, of differentially expressed genes in myeloid cells. Our study shows how CBD is associated with alterations of gene expression in myeloid cells after CBD treatment.

2023-03-31 | GSE228652 | GEO

Proteomic analysis of invasive breast cancer cells treated with CBD reveals new proteins associated with the reversal of their Epithelial-Mesenchymal Transition

Project description:Cannabidiol (CBD) has been used in the treatment of cancer types associated with an inflammatory microenvironment. Although it has been demonstrated that CBD blocks and reverses the epithelial-mesenchymal-transition (EMT) induced by IL-1β, there is limited understanding of how CBD regulates these processes. MCF-7 cells were used to obtain the aggressive phenotype called 6D cells, CBD was then applied to reverse the EMT, to restore a benign epithelial phenotype. In this work, the protein expression in cells going through these processes was analyzed by mass spectrometry. By comparing proteomes of 6D vs. MCF-7 cells, as well as the proteomes of 6D+CBD cells vs. 6D cells or MCF-7 cells, it was foud that GOLGA2, KRT16, and RPRD2 expression was up-regulated by IL-1β and subsequently down-regulated by CBD, and KLHDC7B protein was repressed by IL-1β, and induced by CBD. These observations suggest that these four proteins could represent points of crosstalk between the IL-1β and CBD signaling pathways. Additionally, two protein networks were predicted; one associated with EMT including the proteins BRCA1, MSN, and CORO1A; and other associated with the CBD signaling, consisting of proteins SUPT16H, SETD2, and H2BC12, suggesting that CBD restores the epithelial morphology epigenetically and highlights potential targets for anticancer therapy.

2025-05-16 | PXD059938 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data